duramune adult c3 canine distemper, adenovirus & parvovirus live vaccine
boehringer ingelheim animal health australia pty. ltd. - canine adeno virus type 2; canine distemper virus; canine parvo virus - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus vaccine-viral active 0.0 p; canine parvo virus vaccine-viral active 0.0 p - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine distemper | canine parvovirus | parvovirus
nobivac flex dhppi live vaccine
intervet australia pty limited - canine adeno virus type 2; canine distemper virus; canine parainfluenza virus; canine parvo virus - parenteral liquid/solution/suspension - canine adeno virus type 2 vaccine-viral active 0.0 tci50/do; canine distemper virus vaccine-viral active 0.0 tci50/do; canine parainfluenza virus vaccine-viral active 0.0 tci50/do; canine parvo virus vaccine-viral active 0.0 tci50/do - immunotherapy - dog - with exclusions see label - canine adenovirus - type 1 | canine adenovirus - type 2 | canine distemper | canine parainfluenza | canine parvovirus | hepatitis :- infectious | respiratory disease | canine adenovirus type 1 | canine adenovirus type 2 | infectious canine hepatitis | parvovirus
vanguard 7
pfizer healthcare ireland - canine distemper virus strain n-cdv canine adenovirus, strain manhattan, live attenuated canine parainfluenza, strain nl-cpi-5, live attenuated canine parvovirus, strain nl-35-d, live attenuated leptospira icterohaemorrhagiae inactivated leptospira canicola inactivated - lyophilisate and solvent for solution for injection - canine - immunological - mixed vaccine (live and inactivated)
vanguard cpv
pfizer healthcare ireland - canine parvovirus, strain nl-35-d, live attenuated - solution for injection - canine - immunological - live vaccine
vanguard cpv-l
pfizer healthcare ireland - canine parvovirus, strain nl-35-d, live attenuated leptospira canicola inactivated leptospira icterohaemorrhagiae inactivated - solution for injection - canine - immunological - mixed vaccine (live and inactivated)
nobivac parvo-c
intervet ireland limited - canine parvovirus strain 154 - lyophilisate for suspension for injection - unknown - canine parvovirus vaccine - canine - immunological - live vaccine
versican plus dhppi/l4
zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 6 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae and to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa.
versican plus dhppi/l4r
zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 8–9 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagie serovar icterohaemorrhagiae,to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa and to prevent mortality, clinical signs and infection caused by rabies virus.
canine parvovirus (cpv) strain 154
intervet australia pty limited - canine parvovirus strain 154 - live - unknown - canine parvovirus strain 154 - live vaccine-viral active 0.0 - active constituent
vanguard plus 5/l formulation: each ml of reconstituted vaccine contains: canine distemper (n-cdv)... > 10^3.5 tcid50 canine adenovirus, type 2 (strain manhattan)............> 10^3.4 tcid50 canine parainfluenza (strain nl-cpi-5).......... >10^5.5 tcid50 parvovirus (strain nl-35-d)..............> 10^7.2 tcid50 leptospira interrogans ser. canicola (strain c-51)...........> 600 nu^2 , >1.50 rp^3 leptospira interrogans ser. icterohaemorrhagiae (strain nadl 11403)........................ > 600 nu^2 , >0.40 rp^3 tcid - tissue culture infectious dose nu - nephelometric units rp - relative potency freeze-dried powder for injection (im/sc)
zoetis philippines inc.; distributor: zoetis philippines inc. - modified live virus canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parainfluenza virus (cpiv) , canine parvovirus (cpv) , inactivated leptospira interrogans ser. canicola , l. interrogans ser. icterohaemorrhagiae vaccine (vet.) - freeze-dried powder for injection (im/sc) - formulation: each ml of reconstituted vaccine contains: canine distemper (n-cdv)... > 10^3.5 tcid50 canine adenovirus, type 2 (strain manhattan)............> 10^3.4 tcid50 canine parainfluenza (strain nl-cpi-5).......... >10^5.5 tcid50 parvovirus (strain nl-35-d)..............> 10^7.2 tcid50 leptospira interrogans ser. canicola (strain c-51)...........> 600 nu^2 , >1.50 rp^3 leptospira interrogans ser. icterohaemorrhagiae (strain nadl 11403)........................ > 600 nu^2 , >0.40 rp^3 tcid - tissue culture infectious dose nu - nephelometric units rp - relative potency